Mesenchymal Stem Cell Use in Acute Tendon Injury: In Vitro Tenogenic Potential vs. In Vivo Dose Response

Mesenchymal Stem Cell Use in Acute Tendon Injury: In Vitro Tenogenic Potential vs. In Vivo Dose Response

Stem cell therapy for the treatment of tendon injury is an emerging clinical practice in the fields of human and veterinary sports medicine; however, the therapeutic benefit of intralesional transplantation of mesenchymal stem cells in tendonitis cases is not well designed. Questions persist regardi...

Full description

Bibliographic Details
Main Authors: Kristin Bowers, Lisa Amelse, Austin Bow, Steven Newby, Amber MacDonald, Xiaocun Sun, David Anderson, Madhu Dhar
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Bioengineering
Subjects:
mesenchymal stem cell
tendon
transforming growth factor beta-3
connective tissue growth factor
extracellular matrix
tenogenic differentiation
Online Access:https://www.mdpi.com/2306-5354/9/8/407

Internet

https://www.mdpi.com/2306-5354/9/8/407

Similar Items